Alan Frazier

Commercialization Board Overall Chair

Alan Frazier is the founder and managing partner of Frazier Healthcare. Mr. Frazier assists with evaluating Growth Equity and Biopharma Venture investments. He has been integrally involved in growing several successful early-stage life science companies into national prominence, including Immunex, Affymax and Affymetrix. Mr. Frazier has led several successful investments for the firm such as Tularik and CV Therapeutic. Recently he has led the development of successful growth equity companies such as TridentUSA Health Services.